GlassScriptPhysician profile
Mai-Lynn Bui
NPI 1730628579
$5,056.89
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2021: $286 · 2022: $850 · 2023: $3,023 · 2024: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,688 · Travel and Lodging: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,688.34 |
| Travel and Lodging | $928.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,488.33 | 2022-2023 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $490.57 | 2021-2024 | Ubrelvy, Botox, Qulipta |
| Neurocrine Biosciences, INC. | $318.92 | 2019-2024 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $256.85 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $222.26 | 2022-2024 | Austedo Xr |
| Lilly USA, LLC | $221.73 | 2022-2024 | Emgality, Amyvid, Reyvow |
| Ucb, INC. | $219.46 | 2022-2024 | Briviact, Nayzilam |
| Pfizer INC. | $217.75 | 2023-2024 | |
| Amgen INC. | $177.81 | 2022 | |
| Alexion Pharmaceuticals, INC. | $162.17 | 2022-2023 | Ultomiris, Soliris |
| Biogen, INC. | $135.50 | 2022-2024 | Vumerity, Tysabri, Plegridy |
| Kyowa Kirin, INC. | $122.91 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $115.00 | 2023-2024 | Rexulti |
| Lundbeck LLC | $114.50 | 2021-2024 | Rexulti |
| Allergan, INC. | $86.47 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $79.17 | 2022-2023 | Valtoco |
| Biohaven Pharmaceutical Holding Company LTD. | $78.78 | 2022 | |
| Amneal Pharmaceuticals LLC | $57.79 | 2022-2024 | Rytary |
| Biohaven Pharmaceuticals, INC. | $47.83 | 2021 | |
| Sk Life Science, INC. | $43.45 | 2022-2023 | |
| Impel Pharmaceuticals INC. | $37.27 | 2023 | Trudhesa |
| Genzyme Corporation | $35.59 | 2022 | |
| Ani Pharmaceuticals, INC. | $35.30 | 2023-2024 | Purified Cortrophin Gel |
| Acadia Pharmaceuticals INC | $34.61 | 2023 | Nuplazid |
| Merz Pharmaceuticals, LLC | $34.31 | 2023 | Xeomin |
| Genentech USA, INC. | $31.17 | 2022-2023 | Evrysdi |
| Argenx US, INC. | $30.99 | 2024 | Vyvgart Hytrulo |
| Eisai INC. | $28.71 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $27.76 | 2021 | |
| Averitas Pharma INC. | $23.18 | 2023 | Qutenza |
| Janssen Pharmaceuticals, INC | $22.94 | 2023 | Ponvory |
| Mdd US Operations, LLC | $22.86 | 2023 | Gocovri |
| Banner Life Sciences, LLC | $21.83 | 2022 | |
| Acorda Therapeutics, INC | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mai-Lynn Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.